Biohaven has created a wholly owned subsidiary in Shanghai. BioShin will develop and commercialize Biohaven's migraine and neurology assets in ... read more
Biohaven sets up Shanghai outpost to handle Asia-Pacific portfolio
Biohaven sets up Shanghai outpost to handle Asia-Pacific portfolio